Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vitamin K for Warfarin Associated Coagulopathy
NCT00143715Phase 3Completed
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Sep 2004
- Primary completion
- Oct 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of phytomenadione in coagulopathy (3 arms), sponsored by St. Joseph's Healthcare Hamilton. Primary endpoint: All clinically overt bleeding at 90 days. Started Sep 2004; status: completed.
02
Drugs
phytomenadione
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT00143715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143715.